Key facts
- It has raised $18.9M; the latest was Grant ($840K) in Oct 2025.
- Notable investors include Alumni Ventures, Creative Destruction Lab, University of Toronto, The Engine, Amino Capital — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Axoft
- ·The full record, as it builds
Funding rounds
No funding rounds for Axoft are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Axoft
Developer of implantable electronics designed to amplify brain-machine communication for patients with neurodegenerative conditions. The company offers ultra-flexible plastic mesh implants that integrate multiple sensors, matching the brain's mechanical properties, enabling patients with Parkinson's disease to access effective medical treatment with enhanced precision.
- Sector
- Healthcare
- HQ
- Cambridge, MA, United States
- Founded
- 2021
- Employees
- 31
- Website
- axoft.us/
- Ownership
- Privately Held (backing)
Axoft doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Axoft shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Axoft in its N-PORT filings yet. We sweep new filings monthly.